Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
about
Platelet function inhibitors and platelet function testing in neurointerventional procedures.Oral antiplatelet therapy: impact for transfusion medicine.Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets.Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects.Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue.
P2860
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@en
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@nl
type
label
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@en
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@nl
prefLabel
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@en
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
@nl
P2093
P2860
P356
P1476
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor
@en
P2093
Bernd Jilma
Christa Firbas
Eva-Luise Hobl
Michael Schwameis
Ulla Derhaschnig
P2860
P304
P356
10.1111/ECI.12168
P577
2013-09-23T00:00:00Z